News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,828 Results
Type
Article (49676)
Company Profile (278)
Press Release (683874)
Section
Business (212261)
Career Advice (2098)
Deals (36531)
Drug Delivery (103)
Drug Development (83602)
Employer Resources (173)
FDA (16957)
Job Trends (15706)
News (359186)
Policy (34659)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (2)
Adcomms (23)
Allergies (83)
Alliances (51544)
ALS (87)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (113)
Approvals (16957)
Artificial intelligence (251)
Autoimmune disease (15)
Automation (14)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (191)
Bladder cancer (60)
Brain cancer (25)
Breast cancer (259)
Cancer (2054)
Cardiovascular disease (171)
Career advice (1758)
Career pathing (30)
CAR-T (142)
Cell therapy (401)
Cervical cancer (20)
Clinical research (67643)
Collaboration (791)
Compensation (458)
Complete response letters (21)
COVID-19 (2708)
CRISPR (36)
C-suite (221)
Cystic fibrosis (99)
Data (1986)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (256)
Diagnostics (6547)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (113)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (87)
Earnings (88354)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116664)
Executive appointments (657)
FDA (18105)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (707)
Gene editing (100)
Generative AI (24)
Gene therapy (284)
GLP-1 (736)
Government (4648)
Grass and pollen (4)
Guidances (48)
Healthcare (19896)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (107)
Indications (27)
Infectious disease (2845)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (87)
Interviews (319)
IPO (16852)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (470)
Leadership (16)
Legal (8454)
Liver cancer (73)
Lung cancer (300)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (272)
MASH (64)
Medical device (14326)
Medtech (14331)
Mergers & acquisitions (20158)
Metabolic disorders (667)
Multiple sclerosis (71)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (28)
Neuroscience (1908)
NextGen: Class of 2025 (6911)
Non-profit (4736)
Northern California (2445)
Now hiring (37)
Obesity (362)
Opinion (215)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (77)
Parkinson's disease (137)
Partnered (20)
Patents (206)
Patient recruitment (95)
Peanut (48)
People (59944)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21042)
Phase II (29720)
Phase III (22220)
Pipeline (1051)
Podcasts (57)
Policy (113)
Postmarket research (2741)
Preclinical (8939)
Press Release (67)
Prostate cancer (97)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (367)
Real estate (6297)
Recruiting (65)
Regulatory (23568)
Reports (46)
Research institute (2480)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (4)
RSV (41)
Schizophrenia (71)
Series A (121)
Series B (80)
Service/supplier (13)
Sickle cell disease (51)
Southern California (2126)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (14)
Supply chain (62)
The Weekly (28)
United States (21654)
Vaccines (696)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Today (190)
Last 7 days (701)
Last 30 days (2825)
Last 365 days (34517)
2025 (8264)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (50)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (40877)
Australia (6737)
California (5591)
Canada (1883)
China (491)
Colorado (256)
Connecticut (272)
Delaware (130)
Europe (88482)
Florida (829)
Georgia (202)
Idaho (61)
Illinois (538)
India (23)
Indiana (297)
Iowa (9)
Japan (143)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (869)
Massachusetts (4254)
Michigan (215)
Minnesota (385)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1609)
New Mexico (29)
New York (1608)
North Carolina (983)
North Dakota (7)
Northern California (2445)
Ohio (193)
Oklahoma (14)
Oregon (34)
Pennsylvania (1265)
Puerto Rico (9)
Rhode Island (28)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2126)
Tennessee (94)
Texas (839)
Utah (168)
Virginia (133)
Washington D.C. (61)
Washington State (530)
West Virginia (3)
Wisconsin (50)
733,828 Results for "rakuten medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rakuten Medical Completes Technology Transfer of IR700 Manufacturing and Establishes Exclusive Position in its Supply
February 5, 2025
·
6 min read
Biotech Beach
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
Rakuten Medical, Inc today announced that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024.
May 9, 2024
·
5 min read
Biotech Beach
Rakuten Medical’s Poster Presentation at AACR 2024 Demonstrates Reduction in Photoimmunotherapy-induced Edema in Mice with COX-2 Inhibition
Rakuten Medical, Inc. announced a poster presentation of its study to manage edema following photoimmunotherapy at the 115th Annual Meeting of the American Association for Cancer Research in San Diego, California, on April 8th, 2024.
April 11, 2024
·
7 min read
Biotech Beach
Rakuten Medical to Host R&D Day Highlighting Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 in r/m HNSCC
Rakuten Medical, Inc. today announced that it will host a virtual R&D Day on Thursday, June 20, 2024 at 1:00 pm ET / 10:00 am PT.
May 29, 2024
·
5 min read
Biotech Beach
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform
Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74 million of convertible promissory notes with accrued interest.
March 6, 2024
·
7 min read
Drug Development
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024
Rakuten Medical, Inc. announced the updated safety and efficacy findings from an interim evaluation of an open-label Phase 1b/2 study of photoimmunotherapy using ASP-1929 in combination with anti-PD-1 for recurrent and/or metastatic head and neck squamous cell carcinoma.
May 24, 2024
·
8 min read
Biotech Beach
Rakuten Medical to Present at 2023 Jefferies London Healthcare Conference on November 14
Rakuten Medical, Inc. announced that the Company will present at the 14th Annual Jefferies London Healthcare Conference being held in London, UK, on November 14-16, 2023.
November 2, 2023
·
2 min read
Press Releases
Rakuten Medical Announces New Management Team to Drive the Next Phase of Growth and Innovation
August 20, 2024
·
7 min read
Biotech Beach
Rakuten Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10th, 2024
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy treatments based on its proprietary Alluminox™ platform, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference being held January 8-11, 2024.
December 13, 2023
·
4 min read
Press Releases
Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024
September 20, 2024
·
7 min read
1 of 73,383
Next
